About NeurogesX

NeurogesX is a biopharmaceutical company based in the San Francisco Bay Area. Our focus is on the development of effective treatments that relieve chronic pain and improve quality of life.

Our leading product candidate, NGX-4010, has the potential to revolutionize the treatment of neuropathic pain because a single application may potentially provide months of relief. NGX-4010 is in Phase 3 clinical trials for postherpetic neuralgia (PHN) and pain related to painful HIV-associated distal sensory polyneuropathy (HIV-DSP).

Future plans for NGX-4010 include clinical trials for neuropathic pain related to painful diabetic neuropathy (PDN). We are also developing a next generation non-patch formulation, NGX-1998, and an opioid analgesic for the potential use in treating cancer pain and other severe pain conditions.

About NeurogesX Product Development Pain Information Investor Relations Corporate Governance Financial Information Stock Information Shareholder Tools Careers